February 13, 2019
NIAMS FY 2019 Enacted Level: $605,065,000
The NIAMS is operating under the FY 2019 Department of Defense and Labor, Health and Human Services, and Education Appropriations Act. The interim funding plan below for research and training grants represents the most current information as of the date cited above; however, many factors including a quarterly apportionment of NIAMS approved budget can affect the operating policies, thus they are subject to change. For clarification it is always best to check with an appropriate Institute official.
Research Project Grants (RPGs)
Noncompeting continuation awards will be funded at the recommended level for FY 2019 that is reflected on the FY 2018 Notice of Grant Award.
- Competing R01 applications will be paid through the percentile of 10.0.
- Competing R01 applications from early stage investigators will be paid through the percentile of 22.0.
- Competing R21 applications will be paid through the percentile of 10.0.
- Competing R15 applications will be paid through the percentile of 2.0.
- A payline has not been set for competing R03 applications.
- Reductions from direct costs recommended will be approximately 12 percent. No reductions will be taken on applications with direct costs of $100,000 or less.
- A pool of funds has been set aside for selective payment. Applications chosen for select pay are those that do not fall within the current percentile payline, but which are deemed to have particular relevance to the Institute's scientific and health priorities. Projects to be funded on this basis are recommended by Institute staff and/or Advisory Council members. Applicants may not apply for select pay consideration. Final decisions are made by the Director, NIAMS, following staff discussion.
- Rarely, NIAMS receives an application that is within the Institute's payline, but is deemed to be of low program priority. In such instances, these cases are discussed in depth with members of the National Arthritis and Musculoskeletal and Skin Diseases Advisory Council before the Institute Director makes a final funding decision. An application can be considered low priority for many reasons, including (but not limited to) redundancy with other projects, concerns about the ultimate relevance of the proposed study's results, or a lack of scientific premise.
- A payline has not been set for competing SBIR/STTR applications.
Research Career Awards
- Competing K01/K08/K25 applications will be paid through the priority score 22.
- Competing K23/K24 applications will be paid through the priority score 21.
- A payline has not been set for competing K99 applications.
- Competing research training fellowships (F31, F32, and F33) will be paid through the percentile 20.0.
- A payline has not been set for competing research training fellowships (F30).
- Competing institutional training applications (T32) will be paid through the priority score 20.
No application will be considered for funding until approved by the National Arthritis and Musculoskeletal and Skin Diseases Advisory Council. See Review and Award Cycles.